Women in Uganda have a higher risk of HIV infection during pregnancy

September 29, 2005

In the Rakai district of Uganda pregnant women have higher risk of acquiring HIV than women who are not pregnant, according to a study published in this week's issue of THE LANCET. The researchers controlled for behavioural factors that could affect HIV acquisition and still found this trend; suggesting that biology rather than behaviour is responsible. They believe that hormonal changes during pregnancy could make women more susceptible to HIV infection.

An observational study in Malawi found that HIV acquisition is substantially higher during pregnancy than after giving birth. Another study in Rakai, Uganda suggested similar trends. However, neither of these other studies adjusted for factors that can affect HIV risk.

Ronald Gray (John's Hopkins University, Maryland, USA) and colleagues assessed the incidence rate of HIV during pregnancy and lactation, and compared this to the incidence rate of HIV in women who were not pregnant or breastfeeding. They assessed 2188 HIV-negative sexually active women who were pregnant or breastfeeding and compared rates of HIV acquisition during these periods with 8473 non-pregnant and non-lactating women. The investigators found that the HIV incidence rate was higher during intervals of pregnancy than during breastfeeding, or exposure intervals with no pregnancy or lactation. This excess risk remained significant even after adjustment for sociodemographic or behavioural factors that might increase HIV risk. HIV incidence rates were 2.3 per 100 person years during pregnancy, 1.3 per 100 person years during breastfeeding, and 1.1 per 100 person years in the women who were not pregnant or breastfeeding.

Professor Gray comments: "We cannot generalise our findings beyond the Rakai setting and it would be important for other investigators to verify our results. However, if women are at increased risk of HIV acquisition during pregnancy, our findings represent a public-health problem, both for the mother and possibly her unborn infant. We believe that it would be prudent to warn women of this potential risk of HIV acquisition during pregnancy and promote safe sex or sexual abstinence where feasible."

In an accompanying comment James McIntyre (University of Witwatersrand, Johannesburg, South Africa) states: "The authors have been able to control for sexual behavior to a greater extent than previous reports, and they show little effect of behavioral factors on the increased risk of HIV acquisition in pregnant women suggesting that biological changes in pregnancy have an important role."
-end-
Contact: Professor Ronald H Gray, John Hopkins University, School of Hygiene and Public Health, Dept. Population & Family Health Studies, 615 North Wolfe Street, Baltimore, MD 21205-2179, USA. T) 410 955 7818 rgray@jhsph.edu To reach Professor Gray from Oct 1- Oct 14 contact Jerry Napolitano T) 410 955 7820 jnapolit@jhsph.edu Alternative contact Dr. David Serwadda, T) 011 256 777 6809 dserwada@imul.com

Comment: Dr James A McIntyre, Perinatal HIV Research Unit, University of the Witwatersrand, PO Box 114, Diepkloof, Johannesburg 1864, South Africa. T) +27 11 989 9703 mcintyre@pixie.co.za

Lancet

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.